by Sandi Greenwood | 7th June 2022 | Publication
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer | British Journal of Cancer (nature.com) Dalgleish, A., Stebbing, J., Adamson, D. et al. Randomised, open-label, phase II study of gemcitabine with and...